COMP <GO>
INAB vs INTS // PIOTROSKI F-SCORE QUALITY
IN8bio Inc. (NASDAQ) VS. Intensity Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: INAB 0
— INTS 2
■ METRIC PARITY
LAST: $0.90 (-8.04%) • MKT CAP: $9.7M
piotroski-score
3/9
LAST: $3.40 (+1.80%) • MKT CAP: $10.9M
piotroski-score
3/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INAB VS. INTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INAB | INTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.9 | 45.2 | -4.30 | INTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.7M | $10.9M | -$1.2M | INTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INAB REV | INTS REV | INAB GROSS % | INTS GROSS % | INAB FCF | INTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$12.7M | -$9.2M |
| FY 2024 | $0 | $0 | — | — | -$24.1M | -$15.2M |
| FY 2023 | $0 | $0 | — | — | -$23.3M | -$7.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INAB // BETA —
INTS // BETA —